A Metabolome-Wide Mendelian Randomization Study Identifies Dysregulated Arachidonic Acid Synthesis as a Potential Causal Risk Factor for Bipolar Disorder
Authors:
Open Access
- 22 February 2024
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 96 (6) , 455-462
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- The Ensembl Variant Effect PredictorGenome Biology, 2016
- The Essentiality of Arachidonic Acid in Infant DevelopmentNutrients, 2016
- Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association studyThe Lancet, 2016
- Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary StatisticsPLOS Genetics, 2014
- An atlas of genetic influences on human blood metabolitesNature Genetics, 2014
- Lithium and the Other Mood Stabilizers Effective in Bipolar Disorder Target the Rat Brain Arachidonic Acid CascadeACS Chemical Neuroscience, 2014
- GCTA: A Tool for Genome-wide Complex Trait AnalysisThe American Journal of Human Genetics, 2011
- Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2007
- Family, twin, and adoption studies of bipolar disorderAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2003
- Do Lithium and Anticonvulsants Target the Brain Arachidonic Acid Cascade in Bipolar Disorder?Archives of General Psychiatry, 2002